{"id":13702,"date":"2023-09-14T12:12:23","date_gmt":"2023-09-14T12:12:23","guid":{"rendered":"https:\/\/www.sygnaturediscovery.com\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/"},"modified":"2026-02-11T09:51:12","modified_gmt":"2026-02-11T09:51:12","slug":"lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire","status":"publish","type":"post","link":"https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/","title":{"rendered":"L&rsquo;expertise de Sygnature Discovery en mati\u00e8re de d\u00e9tection de pointe est tr\u00e8s demand\u00e9e, son client en biotechnologie cardiaque, River BioMedics, recevant un investissement d&rsquo;amor\u00e7age suppl\u00e9mentaire de 2 millions d&rsquo;euros."},"content":{"rendered":"<p>Sygnature Discovery est ravie d&rsquo;annoncer que son client, <a href=\"https:\/\/riverbiomedics.com\/\">River BioMedics<\/a> , a lev\u00e9 2 millions d&rsquo;euros suppl\u00e9mentaires en financement d&rsquo;amor\u00e7age pour poursuivre ses recherches sur des m\u00e9dicaments cardiovasculaires vitaux.<\/p>\n<p>Libertatis Ergo Holding, une filiale ind\u00e9pendante de l&rsquo;Universit\u00e9 de Leiden, rejoint le syndicat d&rsquo;investissement aux c\u00f4t\u00e9s d&rsquo;investissements suppl\u00e9mentaires provenant des investisseurs existants FIRST fund, g\u00e9r\u00e9 par BioGeneration Ventures (BGV), KIKK Capital et Oost NL.<\/p>\n<p>La soci\u00e9t\u00e9 de biotechnologie continuera de collaborer avec Sygnature pour faire progresser son portefeuille de projets novateurs et valid\u00e9s g\u00e9n\u00e9tiquement sur les maladies cardiovasculaires.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-15079 size-medium alignleft\" src=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/River-BioMedics_Logo.png\" alt=\"River BioMedics s'associera \u00e0 Sygnature Discovery pour acc\u00e9l\u00e9rer son pipeline de recherche sur des m\u00e9dicaments cardiovasculaires novateurs et valid\u00e9s g\u00e9n\u00e9tiquement.\" width=\"800\" height=\"615\"><\/p>\n<p><span style=\"font-size: 14pt;\">Les deux soci\u00e9t\u00e9s collaborent \u00e0 la d\u00e9couverte de m\u00e9dicaments cardiovasculaires depuis <a href=\"https:\/\/www.sygnaturediscovery.com\/news-and-events\/news\/taking-a-3d-view-of-heart-failure-with-river-biomedics\/\">mars 2021<\/a> . Les programmes ont int\u00e9gr\u00e9 <a href=\"https:\/\/www.sygnaturediscovery.com\/drug-discovery\/integrated-drug-discovery\/fragment-based-drug-discovery\/\">l&rsquo;expertise de Sygnature en mati\u00e8re de d\u00e9veloppement de tests novateurs et d&rsquo;identification de cibles<\/a> avec la technologie unique et de pointe de River BioMedics afin de faire progresser les mod\u00e8les cardiaques 3D <em>in vitro<\/em> pr\u00e9dictifs pour l&rsquo;homme et sa connaissance approfondie de la biologie cardiaque.<\/span><\/p>\n<p><span style=\"font-size: 14pt;\">L&rsquo;objectif de cette entreprise de biotechnologie est de d\u00e9velopper des m\u00e9dicaments qui traitent la cause sous-jacente de l&rsquo;insuffisance cardiaque plut\u00f4t que de simplement en traiter les sympt\u00f4mes. Ce nouvel investissement permet \u00e0 River BioMedics et Sygnature Discovery de renforcer leur partenariat fructueux gr\u00e2ce \u00e0 la poursuite de leurs efforts de recherche et de collaboration dans le domaine des m\u00e9dicaments cardiovasculaires. <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">River BioMedics indique qu&rsquo;elle utilisera ces fonds pour faire progresser le d\u00e9veloppement de compos\u00e9s pour son projet phare, ax\u00e9 sur l&rsquo;insuffisance cardiaque \u00e0 fraction d&rsquo;\u00e9jection pr\u00e9serv\u00e9e, et pour poursuivre ses efforts sur son portefeuille de produits en phase pr\u00e9coce.<\/span><\/p>\n<p><span style=\"font-size: 14pt;\"><a href=\"https:\/\/www.sygnaturediscovery.com\/team-members\/dr-john-unitt\/\">John Unitt, vice-pr\u00e9sident de l&rsquo;inflammation et de l&rsquo;immunologie<\/a> chez Sygnature Discovery, d\u00e9clare&nbsp;:<\/span><\/p>\n<p><span style=\"font-size: 14pt;\">\u00ab C\u2019est formidable que River BioMedics ait obtenu des financements suppl\u00e9mentaires pour soutenir ses recherches en cours sur les m\u00e9dicaments cardiovasculaires et qu\u2019elle continue de collaborer avec Sygnature pour faire progresser ses projets. \u00bb<\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Nicky Cooper, PDG de River BioMedics, d\u00e9clare :<\/span><\/p>\n<p><span style=\"font-size: 14pt;\">\u00ab Nous sommes ravis de disposer de ce financement suppl\u00e9mentaire qui nous permettra de poursuivre notre collaboration avec les scientifiques tr\u00e8s exp\u00e9riment\u00e9s de Sygnature sur nos programmes de d\u00e9couverte de m\u00e9dicaments contre les maladies cardiovasculaires. \u00bb<\/span><\/p>\n<p><span style=\"font-size: 14pt;\">La collaboration entre les deux entreprises se poursuit sur un certain nombre de projets li\u00e9s au syst\u00e8me cardiovasculaire.<\/span><\/p>\n<h2><span style=\"font-size: 14pt;\"><strong>\u00c0 propos de Sygnature Discovery<\/strong><\/span><\/h2>\n<p><span style=\"font-size: 14pt;\">Sygnature Discovery est une soci\u00e9t\u00e9 de recherche contractuelle (CRO) de renomm\u00e9e mondiale, sp\u00e9cialis\u00e9e dans la d\u00e9couverte de m\u00e9dicaments. Implant\u00e9e au Royaume-Uni et au Canada, son si\u00e8ge social se situe \u00e0 Nottingham (Royaume-Uni). Elle poss\u00e8de \u00e9galement des sites \u00e0 Alderley Park, Macclesfield, Glasgow, Montr\u00e9al et Qu\u00e9bec. Son \u00e9quipe de plus de 1&nbsp;000 employ\u00e9s, dont 900 scientifiques, collabore avec des entreprises pharmaceutiques, biotechnologiques et des organismes sans but lucratif du monde entier. Depuis 2004, Sygnature Discovery a d\u00e9velopp\u00e9 plus de 40 nouveaux compos\u00e9s pr\u00e9cliniques et 22 compos\u00e9s cliniques, et ses scientifiques sont signataires de plus de 170 brevets. Ses domaines th\u00e9rapeutiques d&rsquo;expertise comprennent l&rsquo;oncologie, l&rsquo;inflammation et l&rsquo;immunologie, les neurosciences, les maladies m\u00e9taboliques, les maladies infectieuses, les maladies fibrotiques et bien d&rsquo;autres.    <\/span><\/p>\n<p><span style=\"font-size: 14pt;\">Pour plus d&rsquo;informations, consultez <a href=\"https:\/\/www.sygnaturediscovery.com\/\">onesygnaturdev.wpenginepowered.com<\/a><\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-size: 14pt;\"><strong>\u00c0 propos de River BioMedics<\/strong><\/span><\/p>\n<p><span style=\"font-size: 14pt;\">River BioMedics est une soci\u00e9t\u00e9 de d\u00e9couverte de m\u00e9dicaments cardiovasculaires qui int\u00e8gre des technologies de bio-ing\u00e9nierie de pointe d\u00e9velopp\u00e9es en interne \u00e0 une expertise pointue en biologie cardiaque et en d\u00e9couverte de m\u00e9dicaments afin de concevoir des traitements r\u00e9volutionnaires pour les maladies cardiovasculaires. La soci\u00e9t\u00e9 d\u00e9veloppe un portefeuille de petites mol\u00e9cules modifiant l&rsquo;\u00e9volution de la maladie, ciblant des m\u00e9canismes cardiaques valid\u00e9s g\u00e9n\u00e9tiquement, en se concentrant initialement sur l&rsquo;insuffisance cardiaque \u00e0 fraction d&rsquo;\u00e9jection pr\u00e9serv\u00e9e (ICFEP), un domaine o\u00f9 les besoins m\u00e9dicaux sont importants. Sa plateforme de bandes cardiaques 3D est applicable \u00e0 toutes les maladies cardiaques et permet d&rsquo;obtenir une preuve de concept humaine in vitro d\u00e8s les premi\u00e8res \u00e9tapes de la d\u00e9couverte, afin d&rsquo;am\u00e9liorer la transposition des r\u00e9sultats pr\u00e9cliniques aux r\u00e9sultats cliniques.  <\/span><\/p>\n<p>Pour plus d&rsquo;informations, consultez le <a href=\"https:\/\/riverbiomedics.com\/\">site www.riverbiomedics.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":13704,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"category":[817,813],"tags":[799,857,853,896,861,884,859,867,865,824,825,869,852,894,877,882,888,854,890,892,871,863,873,855,879,875,886],"class_list":["post-13702","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-domaines-therapeutiques","category-identification-des-hit","tag-3d-heart-models","tag-biogeneration-ventures-bgv","tag-biologie-cardiaque","tag-biotechnologie-britannique","tag-biotechnologie-canadienne","tag-capitale-kikk","tag-collaboration-en-biotechnologie","tag-composes-cliniques","tag-declarations-du-pdg","tag-decouverte-de-la-signature","tag-decouverte-de-medicaments","tag-developpement-de-composes","tag-developpement-des-essais","tag-financement-de-demarrage","tag-inflammation-et-immunologie","tag-john-unitt","tag-libertatis-ergo-holding","tag-maladies-cardiovasculaires","tag-nicky-cooper","tag-oost-nl","tag-organisation-de-recherche-sous-contrat-cro","tag-recherche-cardiovasculaire","tag-recherche-sur-les-medicaments","tag-river-biomedics","tag-syndicat-dinvestissement","tag-traitement-de-linsuffisance-cardiaque","tag-universite-de-leiden"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>L&#039;expertise de Sygnature Discovery en mati\u00e8re de d\u00e9tection de pointe est tr\u00e8s demand\u00e9e, son client en biotechnologie cardiaque, River BioMedics, recevant un investissement d&#039;amor\u00e7age suppl\u00e9mentaire de 2 millions d&#039;euros. - Sygnature<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/\" \/>\n<meta property=\"og:locale\" content=\"fr_CA\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L&#039;expertise de Sygnature Discovery en mati\u00e8re de d\u00e9tection de pointe est tr\u00e8s demand\u00e9e, son client en biotechnologie cardiaque, River BioMedics, recevant un investissement d&#039;amor\u00e7age suppl\u00e9mentaire de 2 millions d&#039;euros. - Sygnature\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/\" \/>\n<meta property=\"og:site_name\" content=\"Sygnature\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-14T12:12:23+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-11T09:51:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/River-BioMedics_Logo.png\" \/>\n\t<meta property=\"og:image:width\" content=\"828\" \/>\n\t<meta property=\"og:image:height\" content=\"637\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"pnpd-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"pnpd-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimation du temps de lecture\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\\\/\"},\"author\":{\"name\":\"pnpd-admin\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/person\\\/9c173ed9f4225ab61ea895ac3a939448\"},\"headline\":\"L&rsquo;expertise de Sygnature Discovery en mati\u00e8re de d\u00e9tection de pointe est tr\u00e8s demand\u00e9e, son client en biotechnologie cardiaque, River BioMedics, recevant un investissement d&rsquo;amor\u00e7age suppl\u00e9mentaire de 2 millions d&rsquo;euros.\",\"datePublished\":\"2023-09-14T12:12:23+00:00\",\"dateModified\":\"2026-02-11T09:51:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\\\/\"},\"wordCount\":758,\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/River-BioMedics_Logo.png\",\"keywords\":[\"3D Heart Models\",\"BioGeneration Ventures (BGV)\",\"Biologie cardiaque\",\"Biotechnologie britannique\",\"Biotechnologie canadienne\",\"Capitale KIKK\",\"Collaboration en biotechnologie\",\"Compos\u00e9s cliniques\",\"D\u00e9clarations du PDG\",\"D\u00e9couverte de la signature\",\"D\u00e9couverte de m\u00e9dicaments\",\"D\u00e9veloppement de compos\u00e9s\",\"D\u00e9veloppement des essais\",\"Financement de d\u00e9marrage\",\"Inflammation et immunologie\",\"John Unitt\",\"Libertatis Ergo Holding\",\"Maladies cardiovasculaires\",\"Nicky Cooper\",\"Oost NL\",\"Organisation de recherche sous contrat (CRO)\",\"Recherche cardiovasculaire\",\"Recherche sur les m\u00e9dicaments\",\"River BioMedics\",\"Syndicat d'investissement\",\"Traitement de l'insuffisance cardiaque\",\"Universit\u00e9 de Leiden\"],\"articleSection\":[\"Domaines th\u00e9rapeutiques\",\"Identification des HIT\"],\"inLanguage\":\"fr-CA\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\\\/\",\"name\":\"L'expertise de Sygnature Discovery en mati\u00e8re de d\u00e9tection de pointe est tr\u00e8s demand\u00e9e, son client en biotechnologie cardiaque, River BioMedics, recevant un investissement d'amor\u00e7age suppl\u00e9mentaire de 2 millions d'euros. - Sygnature\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/River-BioMedics_Logo.png\",\"datePublished\":\"2023-09-14T12:12:23+00:00\",\"dateModified\":\"2026-02-11T09:51:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\\\/#breadcrumb\"},\"inLanguage\":\"fr-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/River-BioMedics_Logo.png\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/River-BioMedics_Logo.png\",\"width\":828,\"height\":637},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/page-daccueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L&#8217;expertise de Sygnature Discovery en mati\u00e8re de d\u00e9tection de pointe est tr\u00e8s demand\u00e9e, son client en biotechnologie cardiaque, River BioMedics, recevant un investissement d&#8217;amor\u00e7age suppl\u00e9mentaire de 2 millions d&#8217;euros.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"name\":\"Sygnature Discovery\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\"},\"alternateName\":\"Sygnature\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-CA\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#organization\",\"name\":\"Sygnature Discovery\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/Logo.svg\",\"width\":1,\"height\":1,\"caption\":\"Sygnature Discovery\"},\"image\":{\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.sygnaturediscovery.com\\\/fr\\\/#\\\/schema\\\/person\\\/9c173ed9f4225ab61ea895ac3a939448\",\"name\":\"pnpd-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-CA\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g\",\"caption\":\"pnpd-admin\"},\"sameAs\":[\"http:\\\/\\\/www.sygnaturediscovery.com\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L'expertise de Sygnature Discovery en mati\u00e8re de d\u00e9tection de pointe est tr\u00e8s demand\u00e9e, son client en biotechnologie cardiaque, River BioMedics, recevant un investissement d'amor\u00e7age suppl\u00e9mentaire de 2 millions d'euros. - Sygnature","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/","og_locale":"fr_CA","og_type":"article","og_title":"L'expertise de Sygnature Discovery en mati\u00e8re de d\u00e9tection de pointe est tr\u00e8s demand\u00e9e, son client en biotechnologie cardiaque, River BioMedics, recevant un investissement d'amor\u00e7age suppl\u00e9mentaire de 2 millions d'euros. - Sygnature","og_url":"https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/","og_site_name":"Sygnature","article_published_time":"2023-09-14T12:12:23+00:00","article_modified_time":"2026-02-11T09:51:12+00:00","og_image":[{"width":828,"height":637,"url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/River-BioMedics_Logo.png","type":"image\/png"}],"author":"pnpd-admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"pnpd-admin","Estimation du temps de lecture":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/#article","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/"},"author":{"name":"pnpd-admin","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448"},"headline":"L&rsquo;expertise de Sygnature Discovery en mati\u00e8re de d\u00e9tection de pointe est tr\u00e8s demand\u00e9e, son client en biotechnologie cardiaque, River BioMedics, recevant un investissement d&rsquo;amor\u00e7age suppl\u00e9mentaire de 2 millions d&rsquo;euros.","datePublished":"2023-09-14T12:12:23+00:00","dateModified":"2026-02-11T09:51:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/"},"wordCount":758,"publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/River-BioMedics_Logo.png","keywords":["3D Heart Models","BioGeneration Ventures (BGV)","Biologie cardiaque","Biotechnologie britannique","Biotechnologie canadienne","Capitale KIKK","Collaboration en biotechnologie","Compos\u00e9s cliniques","D\u00e9clarations du PDG","D\u00e9couverte de la signature","D\u00e9couverte de m\u00e9dicaments","D\u00e9veloppement de compos\u00e9s","D\u00e9veloppement des essais","Financement de d\u00e9marrage","Inflammation et immunologie","John Unitt","Libertatis Ergo Holding","Maladies cardiovasculaires","Nicky Cooper","Oost NL","Organisation de recherche sous contrat (CRO)","Recherche cardiovasculaire","Recherche sur les m\u00e9dicaments","River BioMedics","Syndicat d'investissement","Traitement de l'insuffisance cardiaque","Universit\u00e9 de Leiden"],"articleSection":["Domaines th\u00e9rapeutiques","Identification des HIT"],"inLanguage":"fr-CA"},{"@type":"WebPage","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/","url":"https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/","name":"L'expertise de Sygnature Discovery en mati\u00e8re de d\u00e9tection de pointe est tr\u00e8s demand\u00e9e, son client en biotechnologie cardiaque, River BioMedics, recevant un investissement d'amor\u00e7age suppl\u00e9mentaire de 2 millions d'euros. - Sygnature","isPartOf":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/#primaryimage"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/River-BioMedics_Logo.png","datePublished":"2023-09-14T12:12:23+00:00","dateModified":"2026-02-11T09:51:12+00:00","breadcrumb":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/#breadcrumb"},"inLanguage":"fr-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/"]}]},{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/#primaryimage","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/River-BioMedics_Logo.png","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/River-BioMedics_Logo.png","width":828,"height":637},{"@type":"BreadcrumbList","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/lexpertise-de-sygnature-discovery-en-matiere-de-detection-de-pointe-est-tres-demandee-son-client-en-biotechnologie-cardiaque-river-biomedics-recevant-un-investissement-damorcage-supplementaire\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sygnaturediscovery.com\/fr\/page-daccueil\/"},{"@type":"ListItem","position":2,"name":"L&#8217;expertise de Sygnature Discovery en mati\u00e8re de d\u00e9tection de pointe est tr\u00e8s demand\u00e9e, son client en biotechnologie cardiaque, River BioMedics, recevant un investissement d&#8217;amor\u00e7age suppl\u00e9mentaire de 2 millions d&#8217;euros."}]},{"@type":"WebSite","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#website","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","name":"Sygnature Discovery","description":"","publisher":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization"},"alternateName":"Sygnature","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sygnaturediscovery.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-CA"},{"@type":"Organization","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#organization","name":"Sygnature Discovery","url":"https:\/\/www.sygnaturediscovery.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","contentUrl":"https:\/\/www.sygnaturediscovery.com\/wp-content\/uploads\/2025\/11\/Logo.svg","width":1,"height":1,"caption":"Sygnature Discovery"},"image":{"@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.sygnaturediscovery.com\/fr\/#\/schema\/person\/9c173ed9f4225ab61ea895ac3a939448","name":"pnpd-admin","image":{"@type":"ImageObject","inLanguage":"fr-CA","@id":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/052476d339a267f4be89460f64dd24ba52137529feafa9cf45d6e8b2b62cda8b?s=96&d=mm&r=g","caption":"pnpd-admin"},"sameAs":["http:\/\/www.sygnaturediscovery.com"]}]}},"_links":{"self":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts\/13702","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/comments?post=13702"}],"version-history":[{"count":0,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/posts\/13702\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media\/13704"}],"wp:attachment":[{"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/media?parent=13702"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/category?post=13702"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sygnaturediscovery.com\/fr\/wp-json\/wp\/v2\/tags?post=13702"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}